Lenvatinib/pembrolizumab combo approved for endometrial cancer

The US Food and Drug Administration (FDA), the Australian Therapeutic Goods Administration (TGA), and Health Canada (HC) have simultaneously approved a two-drug combination for the treatment of advanced endometrial carcinoma. The three agencies worked together under the umbrella of Project Orbis, an initiative that allows concurrent submission and review of oncology products among international partners. The ...